Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liz Robertson
Observed name:
L. Robertson
Institution:
Tracon Pharmaceuticals (United States)
Observed institutions:
Beatson West of Scotland Cancer Centre,
Tracon Pharmaceuticals (United States)
OpenAlex ID:
A5111556069
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma
2022
·
Robin L. Jones
, Vinod Ravi
, et al.
·
JAMA Oncology
·
54
PDF
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)
2021
·
Toni K. Choueiri
, Yousef Zakharia
, et al.
·
The Oncologist
·
11
PDF
Trastuzumab-related Palmar Plantar Erythrodysaesthesia
2011
·
L.M. Tho
, N. Bose
, et al.
·
Clinical Oncology
·
5
Results of the phase II TRAXAR study: A randomized phase II trial of axitinib and TRC105 (TRAX) versus axitinib (AX) alone in patients with advanced or metastatic renal cell carcinoma (mRCC)
2019
·
T.K. Choueiri
, J. Kocsis
, et al.
·
Annals of Oncology
·
4
Show more works
View as search
Works count:
4
Citation count:
73
H-index:
4
I10-index:
2
Year
Topic
Type
